The present study was aimed to test the role of endothelin-1 (ET-1) as a possible autocrine/paracrine growth factor for cardiac fibroblasts, and to examine its interaction with cardiac natriuretic hormones. Expression of preproET-1 (ppET-1) mRNA by cultured cardiac fibroblasts from neonatal rats was demonstrated by Northern blot analysis using cDNA for rat ppET-1 as a probe. Angiotensin II (ANG II) and ET-1 transiently (30 min) increased steady-state ppET-1 mRNA levels in cardiac fibroblasts. Both ET-1 and ANG II significantly stimulated [3H] thymidine incorporation into cardiac fibroblasts, whose effects were dosedependently inhibited by an ETA receptor antagonist (BQ123), BQ123 also inhibited both ET-1-and ANG II-induced ppET-1 mRNA expression. Both atrial and brain natriuretic peptides (ANP, BNP), which activate particulate guanylate cyclase, inhibited ppET-1 mRNA expression and [3H]thymidine incorporation stimulated by ANG II and ET-1. Sodium nitroprusside, a soluble guanylate cyclase activator, and 8-bromocyclic GMP, a membranepermeable cGMP derivative, similarly inhibited ppET-1 mRNA expression and [3H]-thymidine incorporation. BNP was more potent than ANP to inhibit ANG II-and ET-1-stimulated DNA synthesis, whereas BNP and ANP were almost equipotent in stimulating cGMP generation in cardiac fibroblasts. Our data demonstrated that ANG II and ET-1 upregulate ET-1 gene expression in rat cardiac fibroblasts partly via cyclic GMP-dependent mechanism, and that natriuretic peptides inhibit ANG II-stimulated proliferation of cardiac fibroblasts, possibly by inhibiting ET-1 […] 
Introduction
The present study was aimed to test the role of endothelin-1 (ET-1) as a possible autocrine/paracrine growth factor for cardiac fibroblasts, and to examine its interaction with cardiac natriuretic hormones. Expression of preproET-1 (ppET-1) mRNA by cultured cardiac fibroblasts from neonatal rats was demonstrated by Northern blot analysis using cDNA for rat ppET-1 as a probe. Angiotensin H (ANG H) and ET-1 transiently (30 min) increased steady-state ppET-1 mRNA levels in cardiac fibroblasts. Both ET-1 and ANG H significantly stimulated [3H]thymidine incorporation into cardiac fibroblasts, whose effects were dose-dependently inhibited by an ETA receptor antagonist (BQ123). BQ123 also inhibited both ET-1-and ANG H-induced ppET-1 mRNA expression. Both atrial and brain natriuretic peptides (ANP, BNP), which activate particulate guanylate cyclase, inhibited ppET-1 mRNA expression and [3H]thymidine incorporation stimulated by ANG H and ET-1. Sodium nitroprusside, a soluble guanylate cyclase activator, and 8-bromocyclic GMP, a membrane-permeable cGMP derivative, similarly inhibited ppET-1 mRNA expression and [3H]-thymidine incorporation. BNP was more potent than ANP to inhibit ANG H-and ET-1-stimulated DNA synthesis, whereas BNP and ANP were almost equipotent in stimulating cGMP generation in cardiac fibroblasts. Our data demonstrated that ANG H and ET-1 upregulate ET-1 gene expression in rat cardiac fibroblasts partly via cyclic GMPdependent mechanism, and that natriuretic peptides inhibit ANG H-stimulated proliferation of cardiac fibroblasts, possibly by inhibiting ET-1 gene expression. Our data suggest the possible role of endogenous ET-1 as an autocrine/paracrine growth factor for cardiac fibroblasts and its close interaction with natriuretic peptides in the regulation of cardiac fibrosis. Receivedfor publication 12 May 1994 and accepted in revisedform 10 April 1995.
Although cardiomyocytes occupy -75% of the structural space of the heart, they constitute only one third of the total cell population (1, 2). The remaining non-myocytes consist mainly of cardiac fibroblasts in the interstitium. It has been recently shown that growth of cardiac fibroblast associated with enhanced collagen accumulation in the myocardial interstitium is involved in the remodeling process of left ventricular hypertrophy (3, 4) .
Several recent in vivo studies have suggested that angiotensin II (ANG I) 1 is a critical growth factor for cardiac hypertrophy. Treatment with a subdepressor dose of angiotensin-converting enzyme inhibitors (5) and angiotensin receptor antagonists (6) prevent an increase in left ventricular mass. It has been also reported that chronic infusion of a subpressor dose of ANG II into rats causes left ventricular hypertrophy (6) . Since ANG II stimulates cellular proliferation (7) and several extracellular matrix gene expressions in cardiac fibroblasts (8) , and induces cardiomyocyte hypertrophy (9, 10), ANG II is considered to act directly on both cardiomyocytes and fibroblasts.
We (11) and other investigators (12, 13) have previously demonstrated that endothelin-1 (ET-1) induces cardiomyocyte hypertrophy in vitro. Recently, we have further shown that cultured rat cardiomyocytes express abundant preproET-l (ppET-1) transcripts and release mature ET-1 into medium (14) , and that cardiomyocyte hypertrophy stimulated by ANG H is partially blocked by a receptor antagonist selective for ETA subtype ( 14) . These in vitro observations led us to speculate that endogenous ET-1 in cardiomyocytes induced after initial activation of ANG II may be an autocrine/paracrine growth factor for cardiomyocytes. While a direct growth effect of ANG II on cardiac fibroblasts has been well established (7, 8) , subsequent signaling pathways following initial stimulation by ANG H remained unknown. Natriuretic peptide family consists of atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP) and C-type natriuretic peptide (CNP) (15) . Both ANP and BNP are cardiac hormone mainly secreted from atria and ventricles, respectively, while CNP is a neuropeptide. It has been reported that ANP and BNP inhibit proliferation and/or hypertrophy of rat vascular smooth muscle cells and endothelial cells (16 Cell culture and treatment. Primary cultures of neonatal rat cardiac fibroblasts were prepared as previously described (19) . Briefly, the ventricles from 1-or 2-d-old neonatal Wistar rats (Japan Laboratory Animals, Tokyo, Japan) were minced and dissociated with 0.1% collagenase (Sigma Chemical Co.). Dispersed cells were incubated on 100 mm culture dishes (Falcon, Oxnard, CA) for 30 min at 370C in 5% CO2 incubator, and non-myocytes attached to the dish floor were subsequently incubated with minimum essential medium (MEM) supplemented with 10% fetal calf serum, 1 mg/ml insulin and 5 mg/ml transferrin. 2-4 d after seeding, confluent non-myocytes were trypsinized and subcultured. Subconfluent (-70% confluency) cardiac fibroblasts from the second to fourth passage were used for the experiments. 2 h after serum deprivation, cultures were pretreated with test compounds (ANP, BNP, cGMP, SNP, BQ123) for 2 h, followed by treatment with ANG II or ET-1 under a serum-free conditions for the indicated times.
Immunocytochemistry. Immunocytochemical study using rabbit anti-human Factor-VIII, and anti-human a-actin and anti-human vimentin antibody (Dakopatts. Glostrup, Denmark), was performed by the avidin-biotin-peroxidase complex (ABC) method using a Vectastain ABC Kit (Vector Laboratories, Burlingame, CA). Cardiac fibroblasts plated on Tissue Culture Chambers (Nunc Inc. Roskilde, Denmark) were fixed in 4% paraformaldehyde. After blocking intrinsic peroxidase activity with 0.3% H202 in methanol for 30 min, cells were preincubated with 5% of normal goat serum for 30 minutes and incubated with primary antibodies diluted to 1:40 (factor VIII, a-actin) or 1:100 (vimentin) in phosphate-buffered saline (PBS) with 1% bovine serum albumin overnight at 4°C. After washing three times with PBS, the cells were incubated with biotin-conjugated anti-rabbit IgG for 2 h at room temperature. Peroxidase was visualized using the chromogen 3,3'-diaminobenzidine and H202. Counterstaining was performed with hematoxylin. Rat aortic endothelial cells and rat cardiomyocytes were used as positive controls for staining with antibodies for factor VIII and a-actin, respectively.
Northern blot analysis. Northern blot analysis of rat ppET-1 mRNA was performed as reported (14) . In brief, total RNA from neonatal rat cardiac fibroblasts was isolated in guanidine thiocyanate and centrifuged through 5.7 M CsCl cushion (20) RNA was size-fractionated through a 1.4% agarose gel in 0.7 M formaldehyde and 20 mM morpholinopropanesulfonic acid/5 mM sodium acetate/ 1 mM EDTA. Northern blot hybridization was performed with hybridization buffer containing 50% formamide, 5x Denhardt's solution, 100 mg/ml salmon sperm DNA, and Sx SSPE (0.75 M NaCl/0.05 M NaH2PO4/0.005 M EDTA). 32p_ labeled cDNA probes were prepared by the random primer method (21 After completion, cells were rinsed three times with ice-cold PBS, and incubated with 5% trichloroacetic acid (TCA) on ice for 20 min. After washing twice with ice-cold 5% TCA, cells were solubilized in 0.5 N NaOH. An aliquot of TCA-insoluble materials was neutralized with 0.5 N HCl, and radioactivity was determined by a liquid scintillation counter (Model 460CD; Packard Instrument Co. Inc., Meriden, CO). cGMP measurement. Cardiac fibroblasts (4 x 104 cells per well) were preincubated in 1 ml serum-free MEM containing 0.5 mM IBMX for 30 min at 37°C, and then stimulated with ANP, BNP and SNP at 37°C for 30 min. After aspiration of the medium, the reaction was terminated by adding 100 j.l of ice-cold 1 N HCl. After neutralization with 1 N NaOH, concentrations of intracellular cGMP were determined by radioimmunoassay kit (Amersham International. Bucks, UK).
Statistical analyses. One way ANOVA followed by the multiple comparison methods of Scheffe was used for statistical analyses. P < 0.05 was considered significant. Values were expressed as mean±SEM.
Results
Characterization of rat cardiacfibroblasts in culture. Immunocytochemical study revealed that all of cultured cells exhibited positive staining for vimentin (Fig. 1 A) and negative staining for either factor VHI (Fig. 1 B) or a-actin (Fig. 1 C) , indicating that there was no contamination of our rat cardiac fibroblast culture with endothelial cells or myocytes.
Upregulation ofppET-J gene expression by ANG II. Northern blot analysis of total RNA from cultured rat cardiac fibroblasts with cDNA for rat ppET-1 as a probe revealed a distinct band corresponding to the size (2.3 kb) of rat ppET-1 mRNA. ANG 11 (10-8 M) transiently (30 min) increased steady-state levels of ppET-l mRNA which then returned to the basal level after 2 h (Fig. 2) . Expression of c-fos mRNA was also transiently (30 min) induced by ANG H and disappeared thereafter. The ANG II-induced ppET-1 mRNA expression (30 min) was dose-dependent (10-12 10-8 M) (Fig. 3) ; the maximum induction (786±86%, n = 4) was induced with 10-8 M. ppET-J mRNA expression by ET-I and ANG H is mediated through ETA receptor. To determine whether ppET-1 mRNA expression induced by ET-1 and ANG II is mediated via ETA receptor subtype in cardiac fibroblasts, an ETA receptor antagonist (BQ123) was used. As shown in Fig. 4 , upregulation of ppET-1 mRNA induced by both ET-1 (10-8 M) and ANG II (10-8 M) was similarly blocked by BQ123 (10-5 M). DNA synthesis by ANG II and ET-] is mediated through ETA receptor. Both ANG 11 (10-8 M) and ET-1 (10-8 M) significantly (P < 0.05) stimulated [3H]thymidine incorporation into cardiac fibroblasts by 124±6.4% (n = 4) and 133±10% (n = 4) over control, respectively. The stimulatory effects on DNA synthesis by ET-I and ANG H were similarly and significantly (P < 0.05) inhibited by BQ123 (10-i M) (Fig. 5) ; BQ123 alone had no effect on basal [H] thymidine uptake.
Natriuretic peptides, cGMP and SNP inhibit ANG Il-induced ppET-J mRNA expression and DNA synthesis. ANP (10-7 M) and BNP (10-7 M) similarly inhibited the ANG fi (10 -8 M)-stimulated ppET-1 mRNA expression by 45.0±2.7% (n = 4), and 36.7±2.4% (n = 4), respectively (Fig. 6, A M and 4 X 10 -M, respectively (Fig. 8 A) . Likewise, the ET-1 ( 10-8 M)-stimulated [3H]thymidine incorporation was dosedependently inhibited by ANP and BNP with IC50 values of 3 X 10`0 M and 4 X 10-12 M, respectively (Fig. 8 B) . SNP ( 
10-3 M) similarly inhibited [3H]thymidine incorporation stimulated by ANG H (10-8 M) (data not shown).
Production ofcGMP by natriuretic peptides and SNP. Both ANP and BNP dose-dependently (10' 106 M) and equipotently stimulated intracellular cGMP formation in rat cardiac fibroblasts after 30 min of incubation (Fig. 9) genes in cardiac fibroblasts (8) . These data suggest that ANG II-induced cardiac hypertrophy is partly due to increased proliferation of cardiac fibroblasts accompanied by increased formation of extracellular matrix. The present study confirmed these observations and further extended that ET-1, a potent vasoconstrictor peptide, also stimulates DNA synthesis of rat cardiac fibroblasts, suggesting the possible role of two vasoconstrictor peptides (ANG II, ET-1) as growth factors for myocardial remodeling. We ( 11 ) and other investigators ( 13 ) have previously demonstrated that ET-1 induces hypertrophy of cultured rat cardiomyocytes, with the concomitant induction of several cardiac muscles specific genes. Subsequently, we have further shown that cultured rat cardiomyocytes which express ppET-l mRNA, synthesize and secrete mature ET-1 (14) . The present study has demonstrated that ppET-l mRNA is also expressed by rat cardiac fibroblasts, which is upregulated by ANG II in the same manner as in cardiomyocytes. The possible expression of ppET- (11) and vascular smooth muscle cells (27) . In this study, exogenous ET-1 upregulated ppET-1 mRNA expression and stimulated DNA synthesis in cardiac fibroblasts, whose effects were completely inhibited by an ETA receptor antagonist (BQ123). These data suggest that endogenous ET-1 may positively regulate its own gene expression and cell growth through ETA receptors as an autocrine/paracrine factor. Likewise, the ANG II-induced ppET-1 mRNA expression and DNA synthesis in cardiac fibroblasts, were inhibited by BQ123. These data are compatible with those of our previous study using rat cardiomyocytes in which an ETA receptor antagonist partially blocked ppET-1 mRNA expression and protein synthesis stimulated by ANG II (28, 29) . Taken together, it is suggested that ANG II-induced proliferation of cardiac fibroblasts is partly mediated by endogenous ET-l produced by both cardiomyocytes and cardiac fibroblasts in an autocrine/paracrine manner.
The present study clearly demonstrated that cardiac natriuretic peptides (ANP, BNP) inhibited DNA synthesis as well as ppET-1 mRNA expression stimulated by ET-1 and ANG II in rat cardiac fibroblasts. These data suggest that natriuretic peptides have a direct inhibitory effect on proliferation of cardiac fibroblasts. We have previously reported that cardiac fibroblasts possess abundant natriuretic peptide receptors coupled to guanylate cyclase, whose functions remained unsettled at that time (30) . There exist at least three receptor subtypes for natriuretic peptides known to date, namely ANP-A receptor (GC-A), ANP-B receptor (GC-B), and clearance (C) receptor (15) . Both GC-A and GC-B are single transmenbrane receptors containing an extra-cellular binding domain and an intracellular guanylate cyclase domain. The GC-A receptor responds similarly to ANP and BNP, while the GC-B receptor is preferentially activated by CNP (31) . In contrast, C-receptor which lacks the intracellular guanylate cyclase domain, shows non-selective binding affinity for three natriuretic peptides, and has been suggested to mediate sequestration and clearance of circulating natriuretic peptides.
Since both, ANP and BNP equipotently stimulated intracellular cGMP formation in cardiac fibroblasts as demonstrated in this study, it is most likely that natriuretic peptides activate GC-A receptors in cardiac fibroblasts. In this study, SNP which activates soluble guanylate cyclase as well as a membranepermeable derivative 8-bromo-cGMP, similarly inhibited the ANG II-induced ET-1 expression and DNA synthesis in -the same fashion as did natriuretic peptides. Taken together, it is suggested the intracellular cGMP plays a major mediator role in the mechanism of natriuretic peptides-induced inhibition of ppET-1 mRNA expression and DNA synthesis. It has recently been reported that ANP inhibits ET-1-induced activation of mitogen-activated protein (MAP) kinase and translocation of PKC in rat mesangial cells (32). Therefore, one might speculate that cGMP-dependent protein kinase may affect these protein kinases, thereby leading to inhibition of cardiac fibroblasts proliferation (33) .
In the present study, however, the inhibitory effect of BNP on DNA synthesis was about two orders more potent than that of ANP, whereas cGMP production by these two natriuretic peptides was almost equipotent. Such discrepancy may be accounted for by the possible involvement of pathways other than cGMP in natriuretic peptides-induced inhibition of cardiac fibroblast proliferation. It is noteworthy that C-receptor is also involved in inhibition of mitogenesis and proliferation of cultured rat vascular smooth muscle cells via cGMP-independent mechanism. Since rat cardiomyocytes contain both GC-A and C-receptor (34), the more potent inhibition by BNP on DNA synthesis in rat cardiomyocytes may be mediated via C-receptor by the cGMP-independent mechanism. However, the signal transduction of C-receptor in relation to mitogenesis remains to be determined.
It should be also noted that ANP and BNP are both cardiac hormones synthesized by and secreted from cardiomyocytes located very close to cardiac fibroblasts. Therefore, it is possible to speculate that natriuretic peptides may exert their growthinhibitory effects on cardiac fibroblasts in a paracrine manner to counteract growth-promoting effects by two vasoconstrictors, (ANG II and ET-1), via a negative feedback loop. In summary, our study has demonstrated that endogenous ET-1 induced by ANG II in neonatal rat cardiac fibroblasts is an autocrine/paracrine growth factor, and that natriuretic peptides inhibit the proliferation of cardiac fibroblasts stimulated by ET-1 and ANG II. We propose the possible existence of a close interaction between cardiac ET-1 and natriuretic peptides (ANP, BNP), constituting a positive and negative regulatory system for cardiac remodeling.
